MedTrace Logo

The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients With Hematologic Disease

NCT03535220 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2018-05-24

No results posted yet for this study

Summary

This is a multicenter, retrospective and prospective, long-term registry of patients with benign or malignant hematologic diseases, whether or not these patients were or were not treated with disease-specific treatments. Information will be collected on patient demographics, disease characteristics, genomic and molecular data, laboratory data, pathology, radiographic reports, clinical status, quality of life, medications, and dosing information. Where appropriate, these data structures may be based on a combination of Fast Healthcare Interoperability Resources (FHIR) , Consolidated-Clinical Data Architecture (C-CDA) and/or client-specific structure definitions.

Conditions

  • Benign and Malignant Hematologic Diseases

Interventions

COMBINATION_PRODUCT

Protease Inhibitors

Nucleic Acid Synthesis Inhibitors,Hydroxyurea,Antineoplastic Agents

Sponsors & Collaborators

Principal Investigators

  • Alexis Thompson, MD,MPH · Ann & Robert H Lurie Children's Hospital of Chicago

Eligibility

Min Age
1 Year
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-10
Primary Completion
2023-12-31
Completion
2025-01-31
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535220 on ClinicalTrials.gov